Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study III
A Prospective Study for Patients With Lymphoid Malignancy at the Samsung Medical Center
Sponsor: Samsung Genomic Institute
This observational or N/A phase trial investigates Lymphoma, Hodgkin and Lymphoma, Non-Hodgkin and is currently actively recruiting participants. Samsung Genomic Institute leads this study, which shows 18 recorded versions since 2017 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
18 versions recorded-
Sep 2025 — Present [monthly]
Recruiting
-
Jun 2025 — Sep 2025 [monthly]
Recruiting
-
Dec 2024 — Jun 2025 [monthly]
Recruiting
-
Sep 2024 — Dec 2024 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
▶ Show 13 earlier versions
-
Dec 2023 — Jul 2024 [monthly]
Recruiting
-
Jun 2022 — Dec 2023 [monthly]
Recruiting
-
Dec 2021 — Jun 2022 [monthly]
Recruiting
-
Apr 2021 — Dec 2021 [monthly]
Recruiting
-
Jan 2021 — Apr 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Apr 2020 — Nov 2020 [monthly]
Recruiting
-
Feb 2019 — Apr 2020 [monthly]
Recruiting
-
Jun 2018 — Feb 2019 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
May 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Mar 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Samsung Genomic Institute
- Samsung Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .